Overview

Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome

Status:
Terminated
Trial end date:
2018-01-12
Target enrollment:
Participant gender:
Summary
Long-term study to evaluate if macitentan is safe, tolerable and efficient enough to be used for treatment of Eisenmenger syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
Actelion
Treatments:
Macitentan